Navigation Links
Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex®
Date:9/24/2010

de-->

Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex®

 

ARDEE, Ireland, Sept. 24 /PRNewswire-FirstCall/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced that its subsidiaries, Warner Chilcott Company, LLC and Warner Chilcott Finance LLC (together, the "Issuers"), plan to issue an aggregate principal amount of $500 million of 7-3/4% senior notes due 2018 (the "Notes") in a private placement.  The notes are additional notes constituting a part of the same series as the $750 million aggregate principal amount of 7-3/4% senior notes due 2018 issued on August 20, 2010.

The Issuers' obligations under the Notes will be guaranteed by Warner Chilcott plc and by its subsidiaries that guarantee obligations under Warner Chilcott's senior secured credit facilities, subject to certain exceptions.

Warner Chilcott intends to use the net proceeds from the offering to finance its $400 million upfront payment in connection with its pending acquisition of the U.S. rights to Enablex® from Novartis and for general corporate purposes.  

The Notes have not been registered under the Securities Act of 1933, as amended.  The Notes may not be offered or sold within the United States or to U.S. persons, except to "qualified institutional buyers" in reliance on the exemption from registration provided by Rule 144A and to certain persons in offshore transactions in reliance on Regulation S.  This announcement does not constitute an offer to sell or the solicitation of an offer to buy Notes in any jurisdiction in which such an offer or sale would be unlawful.

About Warner ChilcottWarner Chilcott is a leading specialty pharmaceutical company currently focused on the gastroenterology, women's healthcare, dermatology and urology se
'/>"/>

SOURCE Warner Chilcott plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Warner Chilcott to Present at UBS Global Life Sciences Conference
2. Warner Chilcott Announces Receipt of FDA Response to Citizen Petition
3. Warner Chilcott Completes Amendment to Existing Senior Secured Credit Facilities and Closes Senior Notes Offering; Company Declares Special Cash Dividend of $8.50 Per Share and Updates Full-Year 2010 Financial Guidance
4. Warner Chilcott Announces Earnings Release Date and Conference Call for Second Quarter 2010 Financial Results
5. Warner Chilcott Announces 3-Month Extension of PDUFA Date on Next Generation Actonel Product
6. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
7. Warner Chilcott to Present at the Wells Fargo Securities Healthcare Conference
8. Warner Chilcott to Present at the Bank of America Merrill Lynch Healthcare Conference
9. Warner Chilcott Announces Earnings Release Date and Conference Call For First Quarter 2010 Financial Results
10. Warner Chilcott Announces 2010 Financial Guidance Conference Call
11. Warner Chilcott Announces Early Tender Results and Receipt of Consents from a Majority of Holders of its 8-3/4% Senior Subordinated Notes due 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Aug. 27, 2014 Ambit Biosciences (Nasdaq: AMBI ... drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, ... Care Conference to be held at The New York Palace ... September 3-4, 2014. Alan Fuhrman , Ambit,s ... lead drug candidate, quizartinib, at 1:10 p.m. ET on Wednesday, ...
(Date:8/27/2014)... -- After the February 2014 launch of their new ... medical practices and management companies, Prime Clinical is reporting ... "The feedback has been great," says Director of ... of demos and new sign-ups is a reflection of ... of software features." Prime Clinical developed ...
(Date:8/27/2014)... 27, 2014  Zimmer Holdings, Inc. (NYSE and SIX: ... it will be participating in the Morgan Stanley 2014 ... New York, New York , on Tuesday, ... CEO of Zimmer, will be presenting at 9:10 a.m. ... of Biomet, will join Mr. Dvorak for the Q&A ...
Breaking Medicine Technology:Ambit Announces Participation At Baird 2014 Health Care Conference 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 3
(Date:8/27/2014)... The American Brain Tumor Association ... 2014-2016 Basic Research Fellowships and 2014-2015 Discovery Grant Awards. ... is seeding the field with talented, bright young investigators ... the causes, effects, diagnosis and treatment of brain tumors. ... based on the potential to advance the understanding and ...
(Date:8/27/2014)... the onset of a cancer defense mechanism known ... Cancer Center are leveraging it in a new ... cell death rather than survival. The novel treatment ... referred to as the "Trash Man" due to ... autophagy. Results from preclinical experiments suggest this experimental ...
(Date:8/27/2014)... Cash House 's contributions to Horizons ... upkeep of the shelter including new initiatives and a wide ... the lives of each youth who walk through their door. ... for youth ages 16-25. Not only does Horizons operate as ... for the youth who come through their doors. Horizons has ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 IQ ... supplements, today announced its continued support of the Cystic ... Formulations participated in a fundraising campaign led by TigerFitness.com ... of IQ Formulations’ sales were donated to the respected ... to a TigerFitness.com fundraiser to support Isla, a young ...
(Date:8/27/2014)... BCC Research ( http://www.bccresearch.com ) reveals ... AND REGENERATIVE PRODUCTS , the global market for advanced ... by 2014-end to $42.2 billion by 2019, with a ... to 2019. New technologies and an increasingly older population ... market. , While there are many conventional and generally ...
Breaking Medicine News(10 mins):Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 2Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 3Health News:Promising new cancer therapy uses molecular 'Trash Man' to exploit a common cancer defense 2Health News:Cash House a Major Supporter of Horizons for Youth 2Health News:Cash House a Major Supporter of Horizons for Youth 3Health News:IQ Formulations Contributes Sizeable Donation to Cystic Fibrosis Foundation 2Health News:Global Market for Advanced Orthopedic Technology to Reach $42.2 Billion in 2019; Biotechnological Advancements Driving the Market 2Health News:Global Market for Advanced Orthopedic Technology to Reach $42.2 Billion in 2019; Biotechnological Advancements Driving the Market 3
... study report based on detainee interrogations finds that ... not involve physical pain—such as psychological// manipulation, deprivation, ... much mental distress and traumatic stress as physical ... torture encompass both physical and mental pain and ...
... that nearly four out of five hospitalized children receive ... adults//. The authors fear that treating children with off-label ... the magnitude of off-label use of drugs in children," ... specializing in infectious diseases at The Children’s Hospital of ...
... been a success, but continued commitment from the government is ... officials. ,The Immunization Plus Days (IPDs) initiative was ... (NPI) ¯ a government initiative with support from UNICEF and ... 18 northern regions still affected by the virus. ...
... Scientists have developed a test for the early diagnosis of lung ... and off in cells// lining the airways leading to the lungs ... effective. ,Lung cancer is the most deadly form of ... men and the third most common in women. In 2002 about ...
... University researchers have released results of a study showing ... intake//, higher body weight, a decrease in calcium and ... ,The report also noted that studies funded ... show detrimental effects from soft drinks than studies that ...
... the accurate amount of fat in a human body, according// to ... for measuring the amount of fat in a person's body. It ... of their height. ,Generally, a BMI of 25 or ... A person with a higher BMI is thought to be at ...
Cached Medicine News:Health News:All Forms of Ill Treatment Cause Post Traumatic Stress Disorder-PTSD 2Health News:All Forms of Ill Treatment Cause Post Traumatic Stress Disorder-PTSD 3Health News:Prescribing Off Label Drugs for Children may Be Hazardous 2Health News:Prescribing Off Label Drugs for Children may Be Hazardous 3Health News:Nigerian Programme Increases Polio Immunisation 2Health News:Gene Cell Test may Aid Early Lung Cancer Diagnosis 2Health News:Yale Researchers Weigh the Science on Soft Drinks and Health 2
For the quantitative determination of Gamma Glutamyltransferase in serum or plasma...
The CK method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of creatine kinase activity in serum and plasma...
The XCHO method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of cholesterol in serum and plasma....
For the quantitative in vitro determination of Cholesterol in serum and plasma....
Medicine Products: